Profile: Haemacure Corporation specializes in the development of biological adhesives, biomaterials and surgical devices for the acute surgical wound care market. Our Hemaseel HMN is derived from our proprietary technology and is made entirely from human plasma. Our HemaSyst™ is a dual-syringe applicator that has an adapter to enable use with manual sprays, malleable cannula shafts (soft tubes to be inserted into a body cavity), and laparoscopic attachments, it can prevent clogs by keeping solutions separate and incorporates a removable plunger to ensure an accurate solution ratio. Our HemaMyst™ aerosol system offers the ability to economically deliver fluids over a broad area. A focused spray tip allows better surgical access to confined spaces and it is particularly appropriate for soft tissue surgeries such as liver, kidney or pancreas, where fibrin sealant is applied as a fine coating sprayed over the tissue.

The company was founded in 1991, has revenues of < USD 1 Million, has ~50 employees.